Medical Device

Portable Oxygen Concentrators Market Share is Growing with Rising Number of COVID-19 Cases Worldwide

A portable oxygen concentrator (POC) is a tool used to administer oxygen treatment to patients who need greater doses of oxygen than that in normal air. It’s comparable to concentrators with home oxygen (OC), but is reduced in size and more mobile. These devices enable patients to carry their oxygen along with them and help them to continue their usual activities allowing the freedom to continue a normal lifestyle.

Edwards Lifesciences Corporation and Medtronic – Notable Market Players in Portable Oxygen Concentrators Market

Market leaders operating in the market have undertaken various inorganic and organic growth strategies in the portable oxygen concentrators market. The portable oxygen concentrators market majorly consists of the players such as Koninklijke Philips N.V, Caire Inc. (Chart Industries), Inogen Inc., Invacare Corporation, O2 Concepts, Nidek Medical Products, Inc., Drive DeVilbiss International, GCE Group, Besco Medical, and Inova labs Inc. (ResMed). Organic and inorganic growth strategies witnessed in the market include product launches, product approvals and partnerships that have helped to pave way for expansion of business and customer base of market players.

Below is the list of the growth strategies done by the players operating in the portable oxygen concentrators market:

Year News
Nov, 2019 CAIRE, has launched a new FreeStyle Comfort portable oxygen concentrator equipped with autoSAT technology. The device meets FAA guidelines for use on commercial air flights and offers wireless connectivity to CAIRE’s telehealth solution.
Nov, 2016 Invacare Corporation has launched an innovative portable oxygen concentrator, namely Invacare Platinum Mobile Oxygen Concentrator. The product was designed to weather everyday life. Similarly the product is also having Water-Resistance, Rugged Build with temperature tolerance.
Apr, 2016 ResMed has completed the acquisition of Inova Labs Inc., a privately-held medical device company that develops and commercializes innovative oxygen therapy products. With this acquisition the company is likely to expand its product portfolio